Outcomes4Me Secures $21M in Funding Learn more >>

Optimizing NSCLC Treatment with Biomarker Testing Insights

Neither Outcomes4Me nor any participants in or contributors to any webinar, article or content endorses or recommends any products or services. Consult your physician regarding any treatment or therapy.

We recently hosted a webinar called “Optimizing NSCLC Treatment with Biomarker Testing Insights”, featuring Dr. Jessica Lin of Mass General Cancer Center. In it, Dr. Lin discussed how biomarker testing identifies genetic mutations and resistance mechanisms in non-small cell lung treatment, informs better treatment decisions, and influences patient care.  Listen to the replay and learn about the latest advancements that are transforming NSCLC treatment and driving improved patient outcomes. 

Related Webinars

Board-certified pathologist Dr. Michael Misialek shares how to decode your pathology report. Watch the full webinar recording.
Colorectal cancer treatment is evolving, with emerging research challenging long-standing approaches to when and how treatment is given. In this webinar, City of Hope’s Dr. Pashtoon Kasi discusses advances in the treatment of colorectal cancer, including the emerging use of immunotherapy before surgery, known as

Biomarker Testing For Non-Small Cell Lung Cancer Patients